• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多参数磁共振成像定量分析肝细胞癌异质性。

Quantification of hepatocellular carcinoma heterogeneity with multiparametric magnetic resonance imaging.

机构信息

Translational and Molecular Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States.

Department of Radiology, Icahn School of Medicine at Mount Sinai, New York, NY, United States.

出版信息

Sci Rep. 2017 May 26;7(1):2452. doi: 10.1038/s41598-017-02706-z.

DOI:10.1038/s41598-017-02706-z
PMID:28550313
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5446396/
Abstract

Tumour heterogeneity poses a significant challenge for treatment stratification. The goals of this study were to quantify heterogeneity in hepatocellular carcinoma (HCC) using multiparametric magnetic resonance imaging (mpMRI), and to report preliminary data correlating quantitative MRI parameters with advanced histopathology and gene expression in a patient subset. Thirty-two HCC patients with 39 HCC lesions underwent mpMRI including diffusion-weighted imaging (DWI), blood-oxygenation-level-dependent (BOLD), tissue-oxygenation-level-dependent (TOLD) and dynamic contrast-enhanced (DCE)-MRI. Histogram characteristics [central tendency (mean, median) and heterogeneity (standard deviation, kurtosis, skewness) MRI parameters] in HCC and liver parenchyma were compared using Wilcoxon signed-rank tests. Histogram data was correlated between MRI methods in all patients and with histopathology and gene expression in 14 patients. HCCs exhibited significantly higher intra-tissue heterogeneity vs. liver with all MRI methods (P < 0.030). Although central tendency parameters showed significant correlations between MRI methods and with each of histopathology and gene expression, heterogeneity parameters exhibited additional complementary correlations between BOLD and DCE-MRI and with histopathologic hypoxia marker HIF1α and gene expression of Wnt target GLUL, pharmacological target FGFR4, stemness markers EPCAM and KRT19 and immune checkpoint PDCD1. Histogram analysis combining central tendency and heterogeneity mpMRI features is promising for non-invasive HCC characterization on the imaging, histologic and genomics levels.

摘要

肿瘤异质性对治疗分层构成重大挑战。本研究旨在利用多参数磁共振成像(mpMRI)定量评估肝细胞癌(HCC)的异质性,并报告初步数据,这些数据将在患者亚组中关联定量 MRI 参数与高级组织病理学和基因表达。32 例 HCC 患者的 39 个 HCC 病变接受了 mpMRI 检查,包括弥散加权成像(DWI)、血氧水平依赖(BOLD)、组织氧水平依赖(TOLD)和动态对比增强(DCE)-MRI。使用 Wilcoxon 符号秩检验比较 HCC 和肝实质的直方图特征[中央趋势(均值、中位数)和异质性(标准差、峰度、偏度)MRI 参数]。在所有患者中,对直方图数据进行了所有 MRI 方法之间以及与 14 例患者的组织病理学和基因表达之间的相关性分析。与所有 MRI 方法相比,HCC 内部的组织内异质性明显更高(P<0.030)。尽管中央趋势参数与 MRI 方法之间以及与每种组织病理学和基因表达之间均显示出显著相关性,但异质性参数在 BOLD 和 DCE-MRI 之间以及与组织学缺氧标志物 HIF1α和 Wnt 靶基因 GLUL、药理靶基因 FGFR4、干细胞标志物 EPCAM 和 KRT19 以及免疫检查点 PDCD1 的基因表达之间显示出额外的补充相关性。联合中央趋势和异质性 mpMRI 特征的直方图分析有望在影像学、组织学和基因组学水平上实现非侵入性 HCC 特征描述。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe2c/5446396/35879c2c5a52/41598_2017_2706_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe2c/5446396/808122ba1590/41598_2017_2706_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe2c/5446396/0ddfeae05945/41598_2017_2706_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe2c/5446396/ba11a0fe2052/41598_2017_2706_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe2c/5446396/35879c2c5a52/41598_2017_2706_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe2c/5446396/808122ba1590/41598_2017_2706_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe2c/5446396/0ddfeae05945/41598_2017_2706_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe2c/5446396/ba11a0fe2052/41598_2017_2706_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe2c/5446396/35879c2c5a52/41598_2017_2706_Fig5_HTML.jpg

相似文献

1
Quantification of hepatocellular carcinoma heterogeneity with multiparametric magnetic resonance imaging.多参数磁共振成像定量分析肝细胞癌异质性。
Sci Rep. 2017 May 26;7(1):2452. doi: 10.1038/s41598-017-02706-z.
2
Multiparametric FDG-PET/MRI of Hepatocellular Carcinoma: Initial Experience.多参数 FDG-PET/MRI 对肝细胞癌的诊断:初步经验。
Contrast Media Mol Imaging. 2018 Oct 3;2018:5638283. doi: 10.1155/2018/5638283. eCollection 2018.
3
Assessment of Hepatocellular Carcinoma Response to Y Radioembolization Using Dynamic Contrast Material-enhanced MRI and Intravoxel Incoherent Motion Diffusion-weighted Imaging.使用动态对比增强磁共振成像和体素内不相干运动扩散加权成像评估 Y 放射性栓塞治疗肝细胞癌的反应。
Radiol Imaging Cancer. 2020 Jul 24;2(4):e190094. doi: 10.1148/rycan.2020190094.
4
Multiparametric imaging for detection and characterization of hepatocellular carcinoma using gadoxetic acid-enhanced MRI and perfusion-CT: which parameters work best?使用钆塞酸增强磁共振成像(MRI)和灌注CT对肝细胞癌进行检测和特征描述的多参数成像:哪些参数效果最佳?
Cancer Imaging. 2017 Jun 28;17(1):18. doi: 10.1186/s40644-017-0121-9.
5
Intravoxel incoherent motion diffusion-weighted imaging of hepatocellular carcinoma: Is there a correlation with flow and perfusion metrics obtained with dynamic contrast-enhanced MRI?肝细胞癌的体素内不相干运动扩散加权成像:与动态对比增强MRI获得的血流和灌注指标是否存在相关性?
J Magn Reson Imaging. 2016 Oct;44(4):856-64. doi: 10.1002/jmri.25194. Epub 2016 Feb 26.
6
Heterogeneity of non-cancerous liver parenchyma on gadoxetic acid-enhanced MRI: an imaging biomarker for hepatocellular carcinoma development in chronic liver disease.钆塞酸二钠增强MRI上非癌性肝实质的异质性:慢性肝病中肝细胞癌发生的一种影像学生物标志物
Clin Radiol. 2016 May;71(5):432-7. doi: 10.1016/j.crad.2016.01.023. Epub 2016 Mar 2.
7
Performance of gadoxetic acid MRI and diffusion-weighted imaging for the diagnosis of early recurrence of hepatocellular carcinoma.钆塞酸 MRI 和扩散加权成像在诊断肝细胞癌早期复发中的性能。
Eur Radiol. 2020 Jan;30(1):186-194. doi: 10.1007/s00330-019-06351-0. Epub 2019 Aug 1.
8
Quantitative free-breathing dynamic contrast-enhanced MRI in hepatocellular carcinoma using gadoxetic acid: correlations with Ki67 proliferation status, histological grades, and microvascular density.使用钆塞酸行定量自由呼吸动态对比增强 MRI 对肝细胞癌的研究:与 Ki67 增殖状态、组织学分级和微血管密度的相关性。
Abdom Radiol (NY). 2018 Jun;43(6):1393-1403. doi: 10.1007/s00261-017-1320-3.
9
Utility of volumetric contrast-enhanced and diffusion-weighted MRI in differentiating between common primary hypervascular liver tumors.体素增强对比磁共振成像和弥散加权成像在鉴别常见原发性富血供肝肿瘤中的应用。
J Magn Reson Imaging. 2018 Oct;48(4):1080-1090. doi: 10.1002/jmri.26032. Epub 2018 Apr 6.
10
Correlations of MRI manifestations with survivin gene expression in primary hepatic carcinoma.原发性肝癌磁共振表现与生存素基因表达的相关性。
Cancer Biomark. 2018;23(1):45-51. doi: 10.3233/CBM-181285.

引用本文的文献

1
Quantitative Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) in Hepatocellular Carcinoma: A Review of Emerging Applications for Locoregional Therapy.肝细胞癌的定量动态对比增强磁共振成像(DCE-MRI):局部区域治疗新兴应用综述
Bioengineering (Basel). 2025 Aug 12;12(8):870. doi: 10.3390/bioengineering12080870.
2
Radiomics/Radiogenomics in hepatocellular carcinoma: Applications and challenges in interventional management.肝细胞癌中的放射组学/放射基因组学:介入治疗中的应用与挑战
ILIVER. 2022 Aug 1;1(2):96-100. doi: 10.1016/j.iliver.2022.07.001. eCollection 2022 Jun.
3
Prediction of PD-1 Expression and Outcomes of Combined Therapy in Hepatocellular Carcinoma: an MRI-Based Radiomics Approach.

本文引用的文献

1
In-depth tissue profiling using multiplexed immunohistochemical consecutive staining on single slide.在单张载玻片上使用多重免疫组织化学连续染色进行深入的组织分析。
Sci Immunol. 2016 Jul 14;1(1):aaf6925. doi: 10.1126/sciimmunol.aaf6925. Epub 2016 Jun 23.
2
Advanced MRI assessment to predict benefit of anti-programmed cell death 1 protein immunotherapy response in patients with recurrent glioblastoma.采用先进的磁共振成像评估预测复发性胶质母细胞瘤患者抗程序性细胞死亡蛋白1免疫治疗反应的获益情况。
Neuroradiology. 2017 Feb;59(2):135-145. doi: 10.1007/s00234-016-1769-8. Epub 2017 Jan 9.
3
Integrative analysis of diffusion-weighted MRI and genomic data to inform treatment of glioblastoma.
基于MRI的放射组学方法预测肝细胞癌中PD-1表达及联合治疗结果
J Imaging Inform Med. 2025 May 12. doi: 10.1007/s10278-024-01381-7.
4
MRI Parameters and Clinicopathologic Features in Predicting Hepatocellular Carcinomas With Aggressive-Related Marker Expression, Defined by Epithelial Cell Adhesion Molecule and Glypican-3 Status.通过上皮细胞粘附分子和磷脂酰肌醇蛋白聚糖-3状态定义的具有侵袭相关标志物表达的肝细胞癌预测中的MRI参数及临床病理特征
Int J Gen Med. 2025 Mar 26;18:1691-1708. doi: 10.2147/IJGM.S502309. eCollection 2025.
5
Early Enhancement in Contrast-Enhanced Computed Tomography Is an Index of , , , and Expression in Canine Hepatocellular Carcinoma: A Preliminary Study.对比增强计算机断层扫描中的早期强化是犬肝细胞癌中、、、和表达的一个指标:一项初步研究。
Vet Sci. 2025 Feb 7;12(2):137. doi: 10.3390/vetsci12020137.
6
From Images to Genes: Radiogenomics Based on Artificial Intelligence to Achieve Non-Invasive Precision Medicine in Cancer Patients.从图像到基因:基于人工智能的放射基因组学助力癌症患者实现无创精准医疗
Adv Sci (Weinh). 2025 Jan;12(2):e2408069. doi: 10.1002/advs.202408069. Epub 2024 Nov 13.
7
Advanced Imaging of Hepatocellular Carcinoma: A Review of Current and Novel Techniques.肝细胞癌的先进成像:当前及新技术综述
J Gastrointest Cancer. 2024 Dec;55(4):1469-1484. doi: 10.1007/s12029-024-01094-8. Epub 2024 Aug 19.
8
Chip collection of hepatocellular carcinoma based on O heterogeneity from patient tissue.基于患者组织中 O 异质性的肝细胞癌的芯片采集。
Nat Commun. 2024 Jun 15;15(1):5117. doi: 10.1038/s41467-024-49386-8.
9
Multiparametric MRI for characterization of the tumour microenvironment.多参数 MRI 用于肿瘤微环境的特征分析。
Nat Rev Clin Oncol. 2024 Jun;21(6):428-448. doi: 10.1038/s41571-024-00891-1. Epub 2024 Apr 19.
10
Texture analysis on routine MRI sequences to differentiate between focal nodular hyperplasia and hepatocellular adenoma.在常规MRI序列上进行纹理分析以鉴别局灶性结节性增生和肝细胞腺瘤。
Pol J Radiol. 2023 Dec 21;88:e589-e596. doi: 10.5114/pjr.2023.134043. eCollection 2023.
扩散加权磁共振成像与基因组数据的综合分析为胶质母细胞瘤的治疗提供依据。
J Neurooncol. 2016 Sep;129(2):289-300. doi: 10.1007/s11060-016-2174-1. Epub 2016 Jul 8.
4
Advanced Hepatocellular Cancer: the Current State of Future Research.晚期肝细胞癌:当前及未来研究现状
Curr Treat Options Oncol. 2016 Aug;17(8):43. doi: 10.1007/s11864-016-0415-3.
5
Tumor Heterogeneity in Lung Cancer: Assessment with Dynamic Contrast-enhanced MR Imaging.肺癌肿瘤异质性:动态对比增强磁共振成像评估。
Radiology. 2016 Sep;280(3):940-8. doi: 10.1148/radiol.2016151367. Epub 2016 Mar 31.
6
Intravoxel incoherent motion diffusion-weighted imaging of hepatocellular carcinoma: Is there a correlation with flow and perfusion metrics obtained with dynamic contrast-enhanced MRI?肝细胞癌的体素内不相干运动扩散加权成像:与动态对比增强MRI获得的血流和灌注指标是否存在相关性?
J Magn Reson Imaging. 2016 Oct;44(4):856-64. doi: 10.1002/jmri.25194. Epub 2016 Feb 26.
7
DCE-MRI of hepatocellular carcinoma: perfusion quantification with Tofts model versus shutter-speed model--initial experience.肝细胞癌的动态对比增强磁共振成像:采用Tofts模型与快门速度模型进行灌注定量——初步经验
MAGMA. 2016 Feb;29(1):49-58. doi: 10.1007/s10334-015-0513-4. Epub 2015 Dec 8.
8
Molecular classification of hepatocellular carcinoma: potential therapeutic implications.肝细胞癌的分子分类:潜在的治疗意义。
Hepat Oncol. 2015;2(4):371-379. doi: 10.2217/hep.15.26.
9
Therapy Monitoring with Functional and Molecular MR Imaging.功能与分子磁共振成像在治疗监测中的应用
Magn Reson Imaging Clin N Am. 2016 Feb;24(1):261-288. doi: 10.1016/j.mric.2015.08.003.
10
MR Imaging Biomarkers in Oncology Clinical Trials.肿瘤学临床试验中的磁共振成像生物标志物
Magn Reson Imaging Clin N Am. 2016 Feb;24(1):11-29. doi: 10.1016/j.mric.2015.08.002.